Literature DB >> 21394482

Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats.

Emanuela Esposito1, Stefania Mondello, Rosanna Di Paola, Emanuela Mazzon, Domenico Italiano, Irene Paterniti, Patrizia Mondello, Carmela Aloisi, Salvatore Cuzzocrea.   

Abstract

The aim of this study was to investigate the effects of glutamine in an in vivo rat model of renal ischemia/reperfusion (I/R) injury. Male Wistar rats underwent bilateral renal pedicle clamping for 45 min followed by reperfusion for 6 h. Glutamine (1.5 mg/kg) was administered intraperitoneally (i.p.) 15 min prior to reperfusion. Plasma concentrations of urea, creatinine, γ-glutamyl transferase (γ-GT), and aspartate aminotransferase (AST) were measured for the assessment of renal function and reperfusion injury. Markers of oxidative stress, expression of the pro-inflammatory mediators inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), AT-1 expression, and changes in the oxidative stress-sensitive nuclear factor kappa B (NF-κB) signaling pathway were measured to investigate whether glutamine can reduce the renal dysfunction. Kidney myeloperoxidase (MPO) activity and malondialdehyde (MDA) levels were measured for assessment of polymorphonuclear (PMN) cell infiltration and lipid peroxidation, respectively. Renal sections were used for histologic grading of renal injury and for immunohistochemical localization of nitrotyrosine and poly(ADP-ribose) synthetase (PARS). In vivo, glutamine significantly reduced the increase in urea, creatinine, γ-GT, AST, produced by renal ischemia/reperfusion (I/R), suggesting an improvement in both renal function and injury. Glutamine significantly reduced iNOS and NF-κB, kidney MPO activity and MDA levels, indicating a reduction in PMN infiltration and lipid peroxidation, respectively. Glutamine reduced the histological evidence of renal damage associated with I/R and caused a substantial reduction in the staining for nitrotyrosine and PARS, suggesting reduced nitrosative and oxidative stress. Moreover, glutamine attenuated the reduction of COX-2 expression and prevented the increased AT-1 expression after I/R. Our results suggest that glutamine reduces the renal dysfunction and injury associated with I/R of the kidney.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394482     DOI: 10.1007/s00210-011-0610-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  60 in total

1.  Expression and function of Fas (CD95) on human renal tubular epithelial cells.

Authors:  J G Boonstra; F J van der Woude; P C Wever; J C Laterveer; M R Daha; C van Kooten
Journal:  J Am Soc Nephrol       Date:  1997-10       Impact factor: 10.121

2.  Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo.

Authors:  P K Chatterjee; K Zacharowski; S Cuzzocrea; M Otto; C Thiemermann
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

3.  Study of cyclooxygenase-2 in renal ischemia-reperfusion injury.

Authors:  M Matsuyama; R Yoshimura; T Hase; Y Kawahito; H Sano; T Nakatani
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

Review 4.  Obstructive nephropathy and renal fibrosis.

Authors:  Saulo Klahr; Jeremiah Morrissey
Journal:  Am J Physiol Renal Physiol       Date:  2002-11

5.  Effects of an alanyl-glutamine-based oral rehydration and nutrition therapy solution on electrolyte and water absorption in a rat model of secretory diarrhea induced by cholera toxin.

Authors:  Aldo A M Lima; Graça H P Carvalho; Aline A Figueiredo; Angela R Gifoni; Alberto M Soares; Eduardo A T Silva; Richard L Guerrant
Journal:  Nutrition       Date:  2002-06       Impact factor: 4.008

6.  Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation.

Authors:  M A Daemen; C van 't Veer; G Denecker; V H Heemskerk; T G Wolfs; M Clauss; P Vandenabeele; W A Buurman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 7.  Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.

Authors:  Péter Ferdinandy; Richard Schulz
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

8.  Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.

Authors:  Naoyuki Nakao; Ashio Yoshimura; Hiroyuki Morita; Masyuki Takada; Tsuguo Kayano; Terukuni Ideura
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

Review 9.  Current concepts on the pathophysiology of acute renal failure.

Authors:  J H Stein; M D Lifschitz; L D Barnes
Journal:  Am J Physiol       Date:  1978-03

10.  Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium.

Authors:  K M Mullane; R Kraemer; B Smith
Journal:  J Pharmacol Methods       Date:  1985-11
View more
  11 in total

Review 1.  Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Authors:  Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2017-03-26       Impact factor: 8.739

2.  Glutamine prevents oxidative stress in a model of mesenteric ischemia and reperfusion.

Authors:  Gilmara Pandolfo Zabot; Gustavo Franco Carvalhal; Norma Possa Marroni; Renata Minuzzo Hartmann; Vinícius Duval da Silva; Henrique Sarubbi Fillmann
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

3.  Metabolic Intersection of Cancer and Cardiovascular Diseases: Opportunities for Cancer Therapy.

Authors:  Giang Hoang; Kiet Nguyen; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  The Antioxidant Activity of Pistachios Reduces Cardiac Tissue Injury of Acute Ischemia/Reperfusion (I/R) in Diabetic Streptozotocin (STZ)-Induced Hyperglycaemic Rats.

Authors:  Rosanna Di Paola; Roberta Fusco; Enrico Gugliandolo; Ramona D'Amico; Michela Campolo; Saverio Latteri; Arianna Carughi; Giuseppina Mandalari; Salvatore Cuzzocrea
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

5.  Local and Systemic Oxidative Stress in Balkan Endemic Nephropathy Is Not Associated with Xanthine Oxidase Activity.

Authors:  Andrej Veljković; Jovan Hadži-Đokić; Dušan Sokolović; Rade Čukuranović; Jovana Čukuranović-Kokoris; Dragoslav Bašić; Branka Đorđević; Marko Stojanović; Andrija Šmelcerović; Gordana Kocić
Journal:  Oxid Med Cell Longev       Date:  2020-08-18       Impact factor: 6.543

6.  Novel Low-Toxic Derivative of Celastrol Maintains Protective Effect against Acute Renal Injury.

Authors:  Xun Hu; Mengdi Jia; Yu Fu; Pei Zhang; Zhirong Zhang; Qing Lin
Journal:  ACS Omega       Date:  2018-03-06

Review 7.  The Emerging Role of l-Glutamine in Cardiovascular Health and Disease.

Authors:  William Durante
Journal:  Nutrients       Date:  2019-09-04       Impact factor: 5.717

8.  Induction of oxidative stress in kidney.

Authors:  Emin Ozbek
Journal:  Int J Nephrol       Date:  2012-04-17

9.  Oxidative stress and apoptosis in a pig model of brain death (BD) and living donation (LD).

Authors:  Philipp Stiegler; Michael Sereinigg; Andreas Puntschart; Andrea Bradatsch; Thomas Seifert-Held; Iris Wiederstein-Grasser; Bettina Leber; Elke Stadelmeyer; Nadia Dandachi; Siglinde Zelzer; Florian Iberer; Vanessa Stadlbauer
Journal:  J Transl Med       Date:  2013-10-02       Impact factor: 5.531

10.  Elevation in and persistence of multiple urinary biomarkers indicative of oxidative DNA stress and inflammation: Toxicological implications of maleic acid consumption using a rat model.

Authors:  Charlene Wu; Hsin-Chang Chen; Shu-Ting Chen; Su-Yin Chiang; Kuen-Yuh Wu
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.